Scholarly article on selenium(+6) cation 22537-36-6 from Inorganic and Nuclear Chemistry Letters p. 187 - 192

DOI: 10.1016/0020-1650(81)80068-2

Source and publish data:

Inorganic and Nuclear Chemistry Letters p. 187 - 192 (1981)

Update date:2022-07-30

Topics:

Authors:

Dikshitulu, L. S. A.

Vani, P.

Rao, V. Hanumantha

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0020-1650(81)80068-2

Full text of DOI:10.1016/0020-1650(81)80068-2

Products guided by the article

Product name:selenium(+6) cation

Cas No:22537-36-6

R&D Labs maybe for 22537-36-6

Xi'an Herbland Tech Inc.

Contact:+86-29-88710656

Address:South Tai bai Road, High Tech Development Zone, Xi'an China
SunaTech Inc.

Contact:+86 512 6287 2180

Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Shanghai Micro-mega Industry Co., Ltd.

Contact:0086-21-34628682;57153848

Address:Rm413,No.413,West Meilong Road, Minhang District,Shanghai P R China
Hangzhou Taiyan Trading Co., Ltd(expird)

Contact:+86-13777583958

Address:NO.63, Xingyi Street, Xihu District, Hangzhou, Zhejiang, China
SINFACHEM LIMITED

Contact:86-25-84683399

Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002

Relevant to this article

Studies on chromium trioxide-based oxidative coupling reagents and synthesis of lignan-cagayanone

Doi:10.1248/cpb.41.1507
(1993)
Stereoselective synthesis of an erythro N-protected α-amino epoxide derivative

Doi:10.1016/S0040-4039(99)00409-8
(1999)
cis- and trans-3-(3-indolyl)proline derivatives as conformationally restricted analogues of tryptophan

Doi:10.1055/s-1999-2708
(1999)
Prostanoids and related compounds. VII. Synthesis and inhibitory activity of 1-isoindolinone derivatives possessing inhibitory activity against thromboxane A₂ analog (U-46619)-induced vasoconstriction

Doi:10.1248/cpb.47.529
(1999)
Synthetic analogs of xanthocercin

Doi:10.1007/BF02282403
(1998)
Discovery of novel 1,3,5-triazine-thiazolidine-2,4-diones as dipeptidyl peptidase-4 inhibitors with antibacterial activity targeting the S1 pocket for the treatment of type 2 diabetes

Doi:10.1039/c4ra16903d
(2015)

Article Doi

DOI: 10.1016/0020-1650(81)80068-2